Document Details
Form
Filing Date
May 09, 2023
Document Date
March 31, 2023
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
Revance Therapeutics, Inc.
Issuer
REVANCE THERAPEUTICS, INC.
